Omega Fund Management, LLC Long-Term Concentrated

CIK: 0001637359 · Show all filings

Period: Q1 2025 (← Previous) (Next →)

Filing Date: May 15, 2025

Total Value ($000): $169,462 (100.0% shares, 0.0% debt)

Holdings (13)

KMTS Kestra Med Technologies Ltd. 26.4%

Value ($000) $44,754 Shares 1,795,893 Est. Cost $22.98 Unrealized 0.0%

BCAX Bicara Therapeutics Inc. 17.0%

Value ($000) $28,727 Shares 2,204,650 Est. Cost $25.50 Unrealized -47.9%

BBNX Beta Bionics Inc. 14.4%

Value ($000) $24,337 Shares 1,988,287 Est. Cost $18.64 Unrealized 0.0%

NUVB Nuvation Bio 13.6%

Value ($000) $23,007 Shares 13,072,340 Est. Cost $11.18 Unrealized -79.6%

REPL Replimune Group 11.4%

Value ($000) $19,258 Shares 1,975,203 Est. Cost $17.40 Unrealized -28.9%

UPB Upstream Bio Inc. 7.4%

Value ($000) $12,462 Shares 2,036,293 Est. Cost $22.33 Unrealized -57.2%

LXEO Lexeo Therapeutics 2.4%

Value ($000) $4,111 Shares 1,184,636 Est. Cost $12.69 Unrealized -65.1%

ALMS Alumis Inc. 2.4%

Value ($000) $4,011 Shares 653,223 Est. Cost $13.30 Unrealized -56.3%

— Ikena Oncology 1.7%

Value ($000) $2,879 Shares 2,249,123 Est. Cost $28.25 Unrealized —

ENGN enGene Holdings Inc. 1.4%

Value ($000) $2,358 Shares 526,357 Est. Cost $10.40 Unrealized -40.3%

IMUX Immunic Inc. 1.2%

Value ($000) $1,949 Shares 1,788,160 Est. Cost $13.89 Unrealized -92.2%

SANA Sana Biotechnology, Inc. 0.8%

Value ($000) $1,418 Shares 843,750 Est. Cost $32.56 Unrealized -91.4%

ENGNW enGene Holdings Inc. 0.1%

Value ($000) $193 Shares 321,502 Est. Cost $0.85 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
KMTS	Kestra Med Technologies Ltd.	1,795,893	$44,754	26.4%	$22.98	0.0%	Common Stock	G52441105
BCAX	Bicara Therapeutics Inc.	2,204,650	$28,727	17.0%	$25.50	-47.9%	Common Stock	055477103
BBNX	Beta Bionics Inc.	1,988,287	$24,337	14.4%	$18.64	0.0%	Common Stock	08659B102
NUVB	Nuvation Bio	13,072,340	$23,007	13.6%	$11.18	-79.6%	Common Stock Class A	67080N101
REPL	Replimune Group	1,975,203	$19,258	11.4%	$17.40	-28.9%	Common Stock	76029N106
UPB	Upstream Bio Inc.	2,036,293	$12,462	7.4%	$22.33	-57.2%	Common Stock	91678A107
LXEO	Lexeo Therapeutics	1,184,636	$4,111	2.4%	$12.69	-65.1%	Common Stock	52886X107
ALMS	Alumis Inc.	653,223	$4,011	2.4%	$13.30	-56.3%	Common Stock	022307102
—	Ikena Oncology	2,249,123	$2,879	1.7%	$28.25	—	Common Stock	45175G108
ENGN	enGene Holdings Inc.	526,357	$2,358	1.4%	$10.40	-40.3%	Common Stock	29286M105
IMUX	Immunic Inc.	1,788,160	$1,949	1.2%	$13.89	-92.2%	Common Stock	4525EP101
SANA	Sana Biotechnology, Inc.	843,750	$1,418	0.8%	$32.56	-91.4%	Common Stock	799566104
ENGNW	enGene Holdings Inc.	321,502	$193	0.1%	$0.85	—	Warrant	29286M113